+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brain Cancer Drugs Market Research Reports

Pontine Glioma Drugs Market Report 2025 - Product Thumbnail Image

Pontine Glioma Drugs Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Adult Malignant Glioma Therapeutics Market Report 2025 - Product Thumbnail Image

Adult Malignant Glioma Therapeutics Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Brain Tumor Drugs Market Report 2025 - Product Thumbnail Image

Brain Tumor Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Glioblastoma Multiforme (GBM) Treatment Market Report 2025 - Product Thumbnail Image

Glioblastoma Multiforme (GBM) Treatment Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Glioma Treatment Market Report 2025 - Product Thumbnail Image

Glioma Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pediatric Neuroblastoma Treatment Market Report 2025 - Product Thumbnail Image

Pediatric Neuroblastoma Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Gliosarcoma Global Market Report 2025 - Product Thumbnail Image

Gliosarcoma Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Glioblastoma Multiforme Global Market Report 2025 - Product Thumbnail Image

Glioblastoma Multiforme Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Low-Grade Glioma Global Market Report 2025 - Product Thumbnail Image

Low-Grade Glioma Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
From
From
Thymoma - Pipeline Insight, 2025 - Product Thumbnail Image

Thymoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Brain Metastases- Pipeline Insight, 2025 - Product Thumbnail Image

Brain Metastases- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 220 Pages
  • Global
From
Malignant Glioma - Pipeline Insight, 2025 - Product Thumbnail Image

Malignant Glioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Meningioma - Pipeline Insight, 2025 - Product Thumbnail Image

Meningioma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Brain Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Brain Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Gliosarcoma - Pipeline Insight, 2025 - Product Thumbnail Image

Gliosarcoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Pediatric Brain Tumors - Pipeline Insight, 2025 - Product Thumbnail Image

Pediatric Brain Tumors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Brain Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat brain cancer. Brain cancer is a type of cancer that affects the cells of the brain and can be caused by a variety of factors, including genetics, environmental exposure, and lifestyle. Brain cancer drugs are used to treat the symptoms of brain cancer, such as headaches, seizures, and nausea, as well as to slow the progression of the disease. Brain cancer drugs are typically divided into two categories: chemotherapy and targeted therapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific cancer cells and stop them from growing. Both types of drugs are used in combination to treat brain cancer. Some of the major companies in the Brain Cancer Drugs market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. These companies are involved in the development and sale of drugs used to treat brain cancer, as well as in the research and development of new treatments. Show Less Read more